In a reversal from last year, CVS will begin covering Eli Lilly's Zepbound and Foundayo in its standard prescription plan, a ...

A federal appeals court granted Express Scripts Inc. ‘s petition for a jury trial in a case from 120 cities, towns, and counties across West Virginia alleging the company played a central role in the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...

The Federal Trade Commission’s Feb.4 consent order with Express Scripts represents the most consequential structural overhaul of the pharmacy benefit manager industry to date. Policymakers and ...

Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

FTC allegations centered on “Big 3” PBMs using anticompetitive rebating and affiliated-pharmacy channel dynamics to inflate insulin list prices and capture rebate and margin-driven revenues.

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...